Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > J Paul Lytle > Profile

J Paul Lytle

Affiliations

  • Chief Financial Officer at Actuate Therapeutics Inc. (ACTU), 2025-04-02
  • Evp, Chief Financial Officer at Mosaic Immunoengineering Inc. (CPMV), 2021-01-29
  • Chief Financial Officer at Peregrine Pharmaceuticals Inc (PPHM), 2017-04-28
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PPHM $1.34 6,684 $8,956.56 72,051 2010-09-24 Filing
PPHM $1.33 5,000 $6,650.00 65,367 2010-09-23 Filing